Postoperative treatment for head and neck cancer: The emerging role of EGFR-targeted therapy

Athanassios Argiris, Alexander D. Rapidis

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Squamous cell carcinoma of the head and neck (SCCHN) commonly invades local structures and spreads to regional lymph nodes. Treatment with surgery alone is usually inadequate to achieve optimal locoregional control in locally advanced SCCHN, which has led to the use of postoperative radiotherapy in selected high-risk patients (1). Pivotal randomized trials reported in the early 90s showed that postoperative radiotherapy results in better locoregional control than preoperative radiotherapy and that the optimal dose is reached at about 63 Gy (2,3).

Original languageEnglish (US)
Pages (from-to)17-19
Number of pages3
JournalTranslational Cancer Research
Volume5
Issue number1
DOIs
StatePublished - Feb 1 2016
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Postoperative treatment for head and neck cancer: The emerging role of EGFR-targeted therapy'. Together they form a unique fingerprint.

Cite this